Want to join the conversation?
Art business company $BID reported an increase in 2Q16 earnings helped by lower expenses. Net income was $89MM or $1.52 per share in 2Q16 compared to $67.6MM or $0.96 per share in 2Q15. Adjusted net income was $88.6MM or $1.51 per share in 2Q16. Total revenues fell to $298.6MM from last year due to a decrease in net auction sales.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.